Lung cancer: First-in-man phase I trial with lorlatinib.

Related Articles

Lung cancer: First-in-man phase I trial with lorlatinib.

Nat Rev Clin Oncol. 2018 Jan;15(1):7

Authors: Romero D

PMID: 29242590 [PubMed - in process]

http://ift.tt/2zfMRvv